2116 POSTER Nab-Paclitaxel weekly or Q3Wks compared to Docetaxel Q3Wks as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trial

✍ Scribed by G. Dranitsaris; R. Coleman; W.J. Gradishar

• Book ID: 118625720
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 58 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(07)70878-9